These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34487869)

  • 21. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2).
    Leber W; Lammel O; Siebenhofer A; Redlberger-Fritz M; Panovska-Griffiths J; Czypionka T
    EClinicalMedicine; 2021 Aug; 38():101011. PubMed ID: 34278276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders.
    Morlock R; Morlock A; Downen M; Shah SN
    PLoS One; 2021; 16(1):e0245586. PubMed ID: 33481900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
    Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
    Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey.
    Wu DC; Jha P; Lam T; Brown P; Gelband H; Nagelkerke N; Birnboim HC; Reid A;
    PLoS One; 2020; 15(10):e0240778. PubMed ID: 33085714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: survey and qualitative research.
    Mathers J; Poyner C; Thompson D; Rudge G; Pritchett RV
    BMJ Open; 2022 Apr; 12(4):e056606. PubMed ID: 35443954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany.
    Jonczyk R; Stanislawski N; Seiler LK; Blume H; Heiden S; Lucas H; Sarikouch S; Pott PC; Stiesch M; Hauß C; Saletti G; González-Hernández M; Kaiser FK; Rimmelzwaan G; Osterhaus A; Blume C
    Microbiol Spectr; 2022 Feb; 10(1):e0151221. PubMed ID: 35171028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 infection prevalence in people experiencing homelessness.
    Ralli M; De-Giorgio F; Pimpinelli F; Cedola C; Shkodina N; Morrone A; Arcangeli A; Ercoli L
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6425-6430. PubMed ID: 34730224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
    Martin AF; Denford S; Love N; Ready D; Oliver I; Amlôt R; Rubin GJ; Yardley L
    BMC Public Health; 2021 Jun; 21(1):1067. PubMed ID: 34090404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smell and taste disorders in Spanish patients with mild COVID-19.
    Barón-Sánchez J; Santiago C; Goizueta-San Martín G; Arca R; Fernández R
    Neurologia (Engl Ed); 2020; 35(9):633-638. PubMed ID: 32900532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not?
    Beneš J; Džupová O; Poláková A; Sojková N
    Epidemiol Mikrobiol Imunol; 2021; 70(1):3-9. PubMed ID: 33853332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
    Geldsetzer P
    J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of believing you have had COVID-19 on self-reported behaviour: Cross-sectional survey.
    Smith LE; Mottershaw AL; Egan M; Waller J; Marteau TM; Rubin GJ
    PLoS One; 2020; 15(11):e0240399. PubMed ID: 33147219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.